201 related articles for article (PubMed ID: 2163740)
1. [Significance and application of DNA ploidy of bladder cancer cells in studying the malignancy of tumors].
Cao S
Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):143-5. PubMed ID: 2163740
[No Abstract] [Full Text] [Related]
2. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
Toyota K
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
[TBL] [Abstract][Full Text] [Related]
3. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
4. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
[TBL] [Abstract][Full Text] [Related]
6. [DNA ploidy pattern of flow cytometry as indicator of malignancy and prognosis in bladder cancer].
Hosaka Y
Nihon Rinsho; 1992 Oct; 50(10):2426-31. PubMed ID: 1447813
[TBL] [Abstract][Full Text] [Related]
7. [The clinical significance of flow cytometric DNA measurement of paraffin specimen in bladder tumor].
Wang Z
Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):505-8, 512. PubMed ID: 2086120
[TBL] [Abstract][Full Text] [Related]
8. Cytofluorimetric evaluation of DNA ploidy in the diagnosis of bladder cancer.
Armone S; Voce S; dal Pozzo C; Severini G; Montanari F; Monti G; Tavolazzi L
Arch Esp Urol; 1998 Jun; 51(5):507-10. PubMed ID: 9675952
[TBL] [Abstract][Full Text] [Related]
9. Ploidy aberrations and agar cloning ability of malignant cells from human bladder carcinoma.
Høstmark J; Farsund T
Anticancer Res; 1984; 4(3):113-6. PubMed ID: 6465847
[TBL] [Abstract][Full Text] [Related]
10. Feulgen-DNA-values in transitional cell carcinoma of the human urinary bladder.
Fossä SD
Beitr Pathol; 1975 May; 155(1):44-55. PubMed ID: 1156320
[TBL] [Abstract][Full Text] [Related]
11. Bivariate analysis DNA/cytokeratin 7 and flow cytometric measurement of MIB-1 in superficial transitional carcinoma of the bladder (TCC). Methodological aspects and prognostic implications.
Leonardi E; Cristofori A; Reich A; Dalla Palma P
Eur J Histochem; 1997; 41 Suppl 2():133-4. PubMed ID: 9859817
[No Abstract] [Full Text] [Related]
12. DNA flow cytometry: an update of its use in assessing prognosis for transitional cell cancer of the bladder.
Norming U
Semin Urol; 1993 Aug; 11(3):154-63. PubMed ID: 8210836
[No Abstract] [Full Text] [Related]
13. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.
Nenning H; Rassler J; Minh DH; Stolzenburg JU
Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry and prognostic implications in patients with solid tumors.
Williams NN; Daly JM
Surg Gynecol Obstet; 1990 Sep; 171(3):257-66. PubMed ID: 2201096
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy analysis of invasive bladder cancer by flow cytometry.
Badalament RA; Smith JJ; Franklin GL; Drago JR
In Vivo; 1990; 4(4):269-72. PubMed ID: 2103372
[TBL] [Abstract][Full Text] [Related]
16. [Bladder transitional cell carcinoma rating, systematization of grading and value of DNA ploidy].
Hierro Martín I; Alvarez Pérez M; Blanes Berenguel A; Quiñonero Díaz A; Díaz Cano S; García González I; Matilla Vicente A
Actas Urol Esp; 1999 Jun; 23(6):489-96. PubMed ID: 10464957
[TBL] [Abstract][Full Text] [Related]
17. [Multiparameter analysis using flow cytometry as additional tool for bladder cancer diagnosis].
Knuechel R; Wieland W; Nicolai H; Hofstaedter F
Verh Dtsch Ges Pathol; 1993; 77():204-8. PubMed ID: 7511281
[TBL] [Abstract][Full Text] [Related]
18. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors and markers used in urothelial carcinoma of the bladder].
Billerey C; Vieillefond A
Ann Pathol; 1999; 19(5 Suppl):S107-9. PubMed ID: 10599469
[No Abstract] [Full Text] [Related]
20. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
